|
ADNP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.19390000020393E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.71320000022612E-07 |
| Normal-vs-Stage2 |
8.677600E-03 |
| Normal-vs-Stage3 |
3.643000E-03 |
| Normal-vs-Stage4 |
1.960580E-04 |
| Stage1-vs-Stage2 |
2.929800E-01 |
| Stage1-vs-Stage3 |
9.712000E-01 |
| Stage1-vs-Stage4 |
4.190400E-01 |
| Stage2-vs-Stage3 |
4.635400E-01 |
| Stage2-vs-Stage4 |
1.408020E-01 |
| Stage3-vs-Stage4 |
5.382600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.53089999999079E-06 |
| Normal-vs-AfricanAmerican |
1.86548999999703E-05 |
| Normal-vs-Asian |
3.21576099082677E-12 |
| Caucasian-vs-AfricanAmerican |
5.875400E-01 |
| Caucasian-vs-Asian |
4.74650000414911E-08 |
| AfricanAmerican-vs-Asian |
5.77370000000021E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.45709999954668E-07 |
| Normal-vs-Female |
5.616300E-03 |
| Male-vs-Female |
5.331600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.22490000000497E-05 |
| Normal-vs-Extreme_Weight |
4.87019999884097E-08 |
| Normal-vs-Obese |
4.814500E-04 |
| Normal-vs-Extreme_Obese |
5.139800E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.495800E-01 |
| Normal_Weight-vs-Obese |
3.414800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.411400E-01 |
| Extreme_Weight-vs-Obese |
7.335600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.809400E-01 |
| Obese-vs-Extreme_Obese |
8.057000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.420400E-04 |
| Normal-vs-Age(41-60Yrs) |
1.411050E-04 |
| Normal-vs-Age(61-80Yrs) |
3.29649999963877E-07 |
| Normal-vs-Age(81-100Yrs) |
3.72389999999667E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.443800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.487400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.364200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.492200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.267030E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.165600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.30779999996111E-06 |
| Normal-VS-Type2 PRCC |
1.74040000000542E-06 |
| Normal-VS-KIRP CIMP |
8.564100E-02 |
| Normal-VS-Unclassified PRCC |
9.575300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.912800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.354600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.504000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.165600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.634400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.690000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.21839999703377E-08 |
| Normal-vs-N1 |
1.027960E-02 |
| Normal-vs-N2 |
2.359900E-02 |
| N0-vs-N1 |
2.032600E-01 |
| N0-vs-N2 |
8.106800E-01 |
| N1-vs-N2 |
7.127800E-01 |
|
|
